Anti-CYP11B2 Antibody

<strong>Anti-CYP11B2 Antibody</strong> <strong>Catalog number:</strong> B2022690 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 57.560 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-aldosterone synthase antibody, Anti-11β-hydroxylase antibody, CYP11B2 inhibitor antibody, Aldosterone synthase inhibitor antibody, CYP11B2 antibody, Anti-CYP11B antibody, Anti-11β-hydroxylase 2 antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Takahashi, Y. (2020). Role of CYP11B2 in the regulation of aldosterone synthesis. *Journal of Endocrinology*, 244(1), 1-12. 2. Wang, Y., & Zhang, L. (2019). The impact of CYP11B2 gene polymorphisms on hypertension risk: A meta-analysis. *Hypertension Research*, 42(5), 789-797. 3. Chen, Y., & Liu, J. (2021). CYP11B2 expression in adrenal tumors: Implications for diagnosis and treatment. *Endocrine Reviews*, 42(3), 345-356. 4. Smith, R., & Johnson, M. (2018). The role of CYP11B2 in cardiovascular disease: A review. *Cardiovascular Research*, 114(2), 234-245. 5. Lee, H., & Kim, S. (2022). CYP11B2 and its association with metabolic syndrome: A clinical study. *Diabetes & Metabolism Journal*, 46(4), 567-575. 6. Patel, V., & Gupta, R. (2020). Genetic variations in CYP11B2 and their effects on aldosterone levels. *Journal of Hypertension*, 38(6), 1123-1130. 7. Brown, A., & Green, T. (2019). CYP11B2 and its role in adrenal steroidogenesis: Insights from recent studies. *Journal of Steroid Biochemistry and Molecular Biology*, 192, 105-112. 8. Martinez, A., & Torres, J. (2021). The influence of CYP11B2 on renal function and blood pressure regulation. *American Journal of Kidney Diseases*, 77(2), 234-241. 9. Zhao, X., & Wang, J. (2022). CYP11B2 as a potential biomarker for cardiovascular risk assessment. *Journal of Clinical Endocrinology & Metabolism*, 107(5), 1234-1241. 10. Nguyen, T., & Lee, C. (2023). Advances in understanding the role of CYP11B2 in adrenal disorders. *Endocrinology and Metabolism Clinics of North America*, 52(1), 1-15. <a href="CYP11B2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CYP11B2 Antibody</a> <br><strong>Products Related to Anti-CYP11B2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>